Due to the influence of FSHD disease, patients cannot normally choose a suitable major as their physical condition worsens. We hope to provide some advice to some students with #FSHD fshd-china.org/page176.html?a…

Wonderful news from Muscular Dystrophy Association! Thanks to persistent advocacy, Congress has passed the FAA Reauthorization Bill, making significant advancements in accessible air travel. This historic achievement makes air travel more accessible for all. bit.ly/3ynKE2l #accessibility #MDA

This course hopes to give FSHD patients some advice on how to face their own disabilities, how to link resources to realize self-worth, and give FSHD patients and people with disabilities some advice on travel, job hunting, and life. #FSHD #rarediseases fshd-china.org/page176.html?a…

🇨🇳 👉Comprehensive genetic analysis of #FSHD by Nanopore long-read whole-genome sequencing 💡This method detected 17 variations in 3 FSHD2-related genes from nine samples, showing 100% concordance with whole-exome sequencing 📰pubmed.ncbi.nlm.nih.gov/38741136/ FSHD_Diagnosis_Donostia FSHD-China

Today we’re excited to share positive initial data from our Phase 1/2 FORTITUDE™ trial for people living with facioscapulohumeral muscular dystrophy (#FSHD). Read our press release for more information: aviditybiosciences.investorroom.com/2024-06-12-Avi…

Dr. Silvère van der Maarel gave the keynote today at our 31st International Research Congress in Denver! The IRC brings together the world's top FSHD experts. The IRC and ideas shared here have become fundamental in the journey toward treatments.

We’re thrilled that Avidity was recently featured on the Nasdaq tower in NYC’s Times Square in honor of our groundbreaking data from our Phase 1/2 FORTITUDE™ trial in people living with #FSHD. Thank you Nasdaq for the incredible recognition!

We will not stop. From the failed clinical trials, pharmaceutical personnel can get a glimpse of the possibility of success. We believe that we can find a drug to treat #FSHD.

We're grateful for the strong interest in the FORTITUDE study and understand the urgency to bring a potential new treatment to people living with FSHD who have no treatment options. More details in our press release: aviditybiosciences.investorroom.com/2024-10-30-Avi…

🇨🇳 👉Accurate prenatal diagnosis of #FSHD 1 using nanopore sequencing 💡#Nanopore sequencing proves to be an accurate and direct method for #genetic #testing of #monogenic #diseases 📰pubmed.ncbi.nlm.nih.gov/39461849/ @fshd_china

🇪🇺Euromuscular Disorders 643 👉#FSHD Poster 642P 🇨🇳 4qA D4Z4 methylation test as a valuable complement for differential diagnosis in patients with FSHD-like phenotype 💡Distal methylation level is strongly correlated with clinical severity and partially mediated by onset age

Science Magazine Biomarkers of Aging Consortium (2/3) Want to be a part of a future where we can all enjoy living life rather than just surviving it? Register a team today for #XPRIZEHealthspan and the $10M FSHD Bonus Prize by Dec. 20 below. ⬇️ xprize.org/healthspan

👉 Novartis, assessing peers’ muscular dystrophy failures, pens $1.1B deal for gene therapy biotech 👉CEO Vas Narasimhan, M.D., said the pharma is “very interested” in #FSHD & DM1 fiercebiotech.com/biotech/novart…

We announced a partnership with Sarepta Therapeutics to advance programs in rare genetic diseases. We look forward to a long-term collaboration that provide hope to patients with significant unmet needs. Learn more here: bit.ly/4g4I6Xh

Thrilled to share that the Yokota Lab has been ranked #1 in the world for muscular dystrophy research by ScholarGPS ! This recognition is a testament to our team’s dedication to advancing therapies for DMD, FSHD and beyond. Thank you to all supporters! 🧬 scholargps.com/highly-ranked-…

Celebrating the Spirit of the Chinese New Year ! 新春快乐，祝所有FSHD小飞侠所遇皆欢喜，所得皆善良。新的一年，目明心亮，立心力行。#FSHD #ChineseNewYear

The distribution of D4Z4 repeats in China and direct prenatal diagnosis of FSHD by optical genome mapping #FSHD doi.org/10.1186/s13023…

#ArticleinPress: 4qA D4Z4 methylation test as a valuable complement for differential diagnosis in patients with FSHD-like phenotype. Authors from Fudan University and University of Nevada, Reno. Full text: jmdjournal.org/article/S1525-…

Thank you to everyone who joined us for the 2025 International Research Congress & the Industry Collaborative. The festivities are not over! This weekend also includes the inaugural FSHD EU Connect Conference & the Project Mercury Global Task Force meeting. #FSHD #FSHDResearch